NEW YORK (GenomeWeb News) – ShanghaiBio will offer Ingenuity Systems' solutions for downstream analysis and interpretation of genomics data as part of its laboratory services under a deal announced today between the firms.

ShanghaiBio will create a bundled solution with Ingenuity's applications, which combine analytics and biomedical content, supporting the complete workflow from study design to bioinformatic analysis, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.